Phase 2 Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 21 or older
- People who have been diagnosed with pancreatic cancer confirmed by a tissue or cell sample
- People whose cancer is at an advanced stage and cannot be fully removed by surgery (either locally advanced or spread to other parts of the body)
- People whose cancer can be measured on scans using a standard set of measurement guidelines (confirm with trial site)
- People whose doctors estimate they have a life expectancy of at least 12 weeks
- People who are reasonably active and able to care for themselves, with only mild or no limitations on daily activities (confirm with trial site)
- People whose blood cell counts are at an adequate level, as confirmed by blood tests
- People whose liver is functioning well enough, as confirmed by blood tests
- People whose kidneys are functioning well enough, as confirmed by blood tests
- People who are able to give written consent to participate in the trial
Who may not be able to join:
- People who have had another type of cancer within the past 5 years — though some exceptions may apply for certain early-stage or skin cancers, or for people who have been completely free of another cancer for at least 5 years after treatment
- People who have untreated cancer spread to the brain or the lining of the brain and spinal cord — though people whose brain metastases have been treated, are causing no symptoms, and have been stable for 3 or more months may still be considered
- People who have a serious ongoing illness, including severe infection, that could make it unsafe to take part in the trial procedures
- People who have serious medical or mental health conditions that could make it difficult to follow the trial requirements
- People who have received chemotherapy or radiation therapy aimed at managing symptoms within the 4 weeks before joining the trial
- People who have had major surgery within 2 weeks before joining the trial
- People who are currently taking long-term medications that suppress the immune system
- People who are pregnant, breastfeeding, or not using adequate contraception — women who could become pregnant must have a negative pregnancy test within 3 days of joining, and men must either have had a surgical sterilisation procedure or agree to use a barrier method of contraception
- People who are currently taking a specific type of blood-thinning medication known as vitamin K antagonists (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Dr Joycelyn LEE, MBBS, MRCP (UK), M Med, National Cancer Centre, Singapore
Phone: +65 64368000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Overall Response Rate (ORR).; Clinical Benefit Rate (CBR).; The Grade 3-5 Toxicity Rate.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.